Neuraxis reports preliminary Q1 2026 net sales of $1.6M, up 77% YoY; operating loss of $1.7M

Neuraxis, INC

2026-Q1 EPS reported -$0.18 revenue$1,607,883

Cash and cash equivalents ~$7.1M as of March 31, 2026.
Net sales ~$1.6M for Q1 2026, up 77% from ~$0.9M in Q1 2025.
Gross profit ~$1.4M for Q1 2026.
Operating loss ~$1.7M for Q1 2026.
Preliminary unaudited results; final figures may change materially.

item 2.02

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Neuraxis, INC reported the three months ended March 31, 2026 results: revenue approximately $1.6 million.

Period: the three months ended March 31, 2026
Revenue: approximately $1.6 million
Result: preliminary results

Exact text from the filing

On April 21, 2026, Neuraxis, Inc. (the “Company”), issued disclosure that, on a preliminary unaudited basis, the Company expects its cash and cash equivalents to be approximately $7.1 million as of March 31, 2026. The Company expects its net sales to be approximately $1.6 million for the three months ended March 31, 2026, as compared to approximately $0.9 million for the three months ended March 31, 2025.

View on SEC.gov

1341 earnings releases filed in the last 30 days. Browse all earnings releases →

Neuraxis, INC filing history →

Source: SEC EDGAR

accession 0001493152-26-018376

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.